- Tytuł:
- Disease-modifying effects of edasalonexent, an NF-κB inhibitor, in young boys with Duchenne muscular dystrophy: Results of the MoveDMD phase 2 and open label extension trial
- Autorzy:
- Źródło:
- In Neuromuscular Disorders May 2021 31(5):385-396
Czasopismo naukowe